Filing Details

Accession Number:
0001231977-10-000076
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-11-23 16:17:01
Reporting Period:
2010-11-19
Filing Date:
2010-11-23
Accepted Time:
2010-11-23 16:17:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
899866 Alexion Pharmaceuticals Inc ALXN Pharmaceutical Preparations (2834) 133648318
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1337845 Vikas Sinha C/O Alexion Pharmacueticals, Inc.
352 Knotter Drive
Cheshire CT 06410
Svp & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $.0001 Per Share Acquisiton 2010-11-19 20,000 $13.79 93,281 No 4 M Direct
Common Stock, Par Value $.0001 Per Share Disposition 2010-11-19 20,000 $75.00 73,281 No 4 S Direct
Common Stock, Par Value $.0001 Per Share Acquisiton 2010-11-22 4,000 $16.35 77,281 No 4 M Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, Par Value $.0001 Per Share Option to Purchase Common Stock Disposition 2010-11-19 20,000 $0.00 20,000 $13.79
Common Stock, Par Value $.0001 Per Share Option to Purchase Common Stock Disposition 2010-11-22 4,000 $0.00 4,000 $16.35
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
40,000 2005-12-21 2015-09-21 No 4 S Direct
0 2006-09-07 2016-06-07 No 4 S Direct
Footnotes
  1. The transaction reported by this Form 4 are made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act.